MacroGenics | MGNX - Attività





Attività Cambiamento Data
AbbVie USD 147.68B 12.57B 2026-09
Amgen USD 96.05B 409M 2026-09
AstraZeneca USD 119.92B 4.09B 2026-09
Biogen USD 32.05B 32.5M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Daiichi Sankyo JPY 4.26T 144.08B 2026-09
Eli Lilly USD 148.07B 5.79B 2026-09
Genmab DKK 12.52B 139M 2026-06
Geron USD 527.11M 8.1M 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
J&J USD 197.42B 3.64B 2026-09
Karyopharm Therapeutics USD 131.42M 23M 2026-03
MacroGenics USD 318.68M 26.72M 2026-09
Merck USD 132.77B 2.97B 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Xencor USD 770.5M 45.54M 2026-09